118 related articles for article (PubMed ID: 21079327)
1. Serpentine supravenous pigmentation. A rare vasculo-cutaneous effect induced by systemic 5-fluorouracil.
Rao R; Balachandran C
Indian J Dermatol Venereol Leprol; 2010; 76(6):714-5. PubMed ID: 21079327
[No Abstract] [Full Text] [Related]
2. Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy.
Geddes ER; Cohen PR
South Med J; 2010 Mar; 103(3):231-5. PubMed ID: 20134385
[TBL] [Abstract][Full Text] [Related]
3. Images in clinical medicine. Serpentine supravenous hyperpigmentation.
Chan CC; Lin SJ
N Engl J Med; 2010 Jul; 363(5):e8. PubMed ID: 20830826
[No Abstract] [Full Text] [Related]
4. Serpentine supravenous streaks induced by 5-fluorouracil.
Jain V; Bhandary S; Prasad GN; Shenoi SD
J Am Acad Dermatol; 2005 Sep; 53(3):529-30. PubMed ID: 16112371
[No Abstract] [Full Text] [Related]
5. Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
Chen GY; Lee JY; Chen WC
Br J Dermatol; 2005 Jun; 152(6):1383-5. PubMed ID: 15949026
[No Abstract] [Full Text] [Related]
6. Serpentine supravenous 5-fluorouracil (NSC-19893) hyperpigmentation.
Hrushesky WJ
Cancer Treat Rep; 1976 May; 60(5):639. PubMed ID: 991154
[No Abstract] [Full Text] [Related]
7. Persistent serpentine supravenous hyperpigmentation--a possible cutaneous manifestation of HIV infection or a normal racial variant: a report of 3 cases.
O'Malley JT; Lieb JL; Weiser JA; Grossman ME
Skinmed; 2013; 11(2):93-4. PubMed ID: 23745227
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous hyperpigmentation during therapy with hydroxychloroquine.
Amichai B; Gat A; Grunwald MH
J Clin Rheumatol; 2007 Apr; 13(2):113. PubMed ID: 17414546
[No Abstract] [Full Text] [Related]
9. Letter: Serpentine supravenous fluorouracil hyperpigmentation.
Hrushesky WJ
JAMA; 1976 Jul; 236(2):138. PubMed ID: 947001
[No Abstract] [Full Text] [Related]
10. Serpentine supravenous hyperpigmentation resulting from vinorelbine administration.
Roach EC; Petekkaya I; Gezgen G; Ünlü O; Altundag K
Breast J; 2015; 21(3):311-2. PubMed ID: 25808569
[No Abstract] [Full Text] [Related]
11. Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
Fukushima S; Hatta N
Br J Dermatol; 2004 Sep; 151(3):698-700. PubMed ID: 15377362
[TBL] [Abstract][Full Text] [Related]
12. Serpentine supravenous hyperpigmentation induced by chemotherapy: a systematic review.
Shan J; Obiakor BC; Cheng J; Francois RA; Dobry AS
Arch Dermatol Res; 2024 May; 316(6):215. PubMed ID: 38787426
[TBL] [Abstract][Full Text] [Related]
13. Serpentine Supra-venous Hyperpigmentation "Badge of Courage" in Fight Against Cancer: An Brief Review.
Narayan S; Talwar V; Redhu P; Goel V; Jain A; Soni S; Chaudhary K; Basu D
Gulf J Oncolog; 2022 Sep; 1(40):83-87. PubMed ID: 36448076
[TBL] [Abstract][Full Text] [Related]
14. Pigmented contact dermatitis due to kojic acid. A paradoxical side effect of a skin lightener.
García-Gavín J; González-Vilas D; Fernández-Redondo V; Toribio J
Contact Dermatitis; 2010 Jan; 62(1):63-4. PubMed ID: 20136888
[No Abstract] [Full Text] [Related]
15. 5-Fluorouracil-induced bilateral persistent serpentine supravenous hyperpigmented eruption, bilateral mottling of palms and diffuse hyperpigmentation of soles.
Suvirya S; Agrawal A; Parihar A
BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25336557
[TBL] [Abstract][Full Text] [Related]
16. Unusual serpentine hyperpigmentation associated with 5-fluorouracil. Case report and review of cutaneous manifestations associated with systemic 5-fluorouracil.
Vukelja SJ; Bonner MW; McCollough M; Cobb PW; Gaule DA; Fanucchi PJ; Keeling JH
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):905-8. PubMed ID: 1837033
[TBL] [Abstract][Full Text] [Related]
17. Unusual pigmentary changes associated with 5-fluorouracil therapy.
Hrushesky WJ
Cutis; 1980 Aug; 26(2):181-82. PubMed ID: 7408538
[TBL] [Abstract][Full Text] [Related]
18. [Pigmentary disorders induced by anticancer agents. part I: chemotherapy].
Sibaud V; Fricain JC; Baran R; Robert C
Ann Dermatol Venereol; 2013 Mar; 140(3):183-96. PubMed ID: 23466151
[TBL] [Abstract][Full Text] [Related]
19. Letter: Docetaxel-induced supravenous serpentine dermatitis.
Ghosh SK; Bandyopadhyay D; Ghoshal L; Basu S
Dermatol Online J; 2011 Nov; 17(11):16. PubMed ID: 22136872
[TBL] [Abstract][Full Text] [Related]
20. Serpentine supravenous hyperpigmentation related to carboplatin and vinorelbine chemotherapy: A case report.
Akyurek FT; Sari N; Ugurluoglu C; Kurtipek GS
Dermatol Ther; 2019 Jul; 32(4):e12981. PubMed ID: 31168954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
